L 66/40
EN
Official Journal of the European Union
4.3.2004
ANNEX I
Pursuant to paragraph 3 of Decision XII/2 of the twelfth meeting of the Parties to the Montreal Protocol on measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers (MDIs), the following Parties have determined in December 2002 that, due to the presence of suitable non-CFC MDIs, CFCs no longer qualify as ‘essential’ according to the Protocol when combined with following products:
List of non-essential substances
| Product Country |
Salbutamol | Terbutaline | Fenoterol | Orciprenaline | Reproterol | Carbuterol | Hexoprenaline | Pirbuterol | Clenbuterol | Biloterol | Procaterol |
| Austria | x | x | x | x | x | x | x | x | x | x | x |
| Belgium | x | x | x | x | x | x | x | x | x | x | x |
| Denmark | x | x | x | x | x | x | x | x | x | x | |
| Finland | x | ||||||||||
| France | x | ||||||||||
| Germany | x | x | x | x | x | x | x | x | x | x | x |
| Greece | x | x | x | x | x | x | x | x | x | x | x |
| Ireland | x | ||||||||||
| Luxembourg | x | ||||||||||
| Norway | x | x | x | x | x | x | x | x | x | x | x |
| Portugal | x | x | x | x | x | x | x | x | x | x | x |
| The Netherlands | x | x | x | x | x | x | x | x | x | x | x |
| United Kingdom | x | ||||||||||
Source: www.unep.org/ozone/dec12-2-3.pdf
